• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

催乳素瘤青少年患者早期手术治疗的可行性:病例报告及文献复习。

Feasibility of Early Surgical Treatment for Adolescent Patients with Prolactinoma: A Case Report and Literature Review.

机构信息

Department of Neurosurgery, Chung Shan Medical University Hospital, Taichung 40201, Taiwan.

Department of Neurosurgery, Neurological Institute, Taichung Veterans General Hospital, Taichung 40705, Taiwan.

出版信息

Medicina (Kaunas). 2024 Aug 19;60(8):1345. doi: 10.3390/medicina60081345.

DOI:10.3390/medicina60081345
PMID:39202626
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11356365/
Abstract

: Prolactinomas are the most common pituitary adenomas, comprising 30-50% of such tumors. These adenomas cause hyperprolactinemia, leading to decreased fertility, reduced energy and libido, and galactorrhea. Diagnosing and treating prolactinomas in adolescents present unique challenges, as symptoms may be confused with age-related developmental variations. This case report explores the outcomes of early surgical intervention in an adolescent with a prolactinoma. : A 14-year-old female presented delayed menarche and absent pubertal development. Initial evaluation revealed hyperprolactinemia (228.37 ng/mL) with normal estradiol levels. Initial management through observation was adopted, but persistent amenorrhea and severe headaches prompted further investigation. Magnetic resonance imaging revealed a cystic pituitary mass with apoplexy. Due to concerns regarding delayed puberty and the need for rapid normalization of prolactin levels, the patient underwent transsphenoidal surgery. After operation, prolactin levels normalized, menarche occurred within three months, and secondary sexual characteristics developed within eight months. Pathology confirmed a pituitary adenoma with a high Ki-67 index (15%). : Early surgical intervention for prolactinomas in adolescents can achieve successful biochemical remission and resolution of endocrine symptoms. Adolescents, particularly those with a high Ki-67 index and potential resistance to dopamine agonists, may benefit from prompt surgical management, resulting in improved clinical outcomes and complete tumor resection.

摘要

催乳素瘤是最常见的垂体腺瘤,占此类肿瘤的 30-50%。这些腺瘤导致高泌乳素血症,导致生育能力下降、能量和性欲降低以及泌乳。青少年催乳素瘤的诊断和治疗存在独特的挑战,因为症状可能与年龄相关的发育变化相混淆。本病例报告探讨了对青少年催乳素瘤患者进行早期手术干预的结果。

一名 14 岁女性出现月经初潮延迟和青春期发育缺失。初步评估显示高泌乳素血症(228.37ng/ml),雌二醇水平正常。最初通过观察进行治疗,但持续的闭经和严重头痛促使进一步检查。磁共振成像显示垂体肿块伴卒中。由于担心青春期延迟和需要迅速使泌乳素水平正常化,患者接受了经蝶窦手术。术后,泌乳素水平正常化,三个月内出现初潮,八个月内出现第二性征。病理证实为高 Ki-67 指数(15%)的垂体腺瘤。

青少年催乳素瘤的早期手术干预可以实现生化缓解和内分泌症状的解决。对于青少年,特别是那些 Ki-67 指数较高且可能对多巴胺激动剂有抗性的患者,及时的手术治疗可能会带来更好的临床结果和肿瘤完全切除。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45c8/11356365/6f191bbe30e3/medicina-60-01345-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45c8/11356365/c2a7a25dd9f0/medicina-60-01345-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45c8/11356365/90d6225c6bba/medicina-60-01345-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45c8/11356365/5d6156593392/medicina-60-01345-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45c8/11356365/6f191bbe30e3/medicina-60-01345-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45c8/11356365/c2a7a25dd9f0/medicina-60-01345-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45c8/11356365/90d6225c6bba/medicina-60-01345-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45c8/11356365/5d6156593392/medicina-60-01345-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/45c8/11356365/6f191bbe30e3/medicina-60-01345-g004.jpg

相似文献

1
Feasibility of Early Surgical Treatment for Adolescent Patients with Prolactinoma: A Case Report and Literature Review.催乳素瘤青少年患者早期手术治疗的可行性:病例报告及文献复习。
Medicina (Kaunas). 2024 Aug 19;60(8):1345. doi: 10.3390/medicina60081345.
2
Time Course of Resolution of Hyperprolactinemia After Transsphenoidal Surgery Among Patients Presenting with Pituitary Stalk Compression.垂体柄受压患者经蝶窦手术后高泌乳素血症缓解的时间进程。
World Neurosurg. 2017 Jan;97:2-7. doi: 10.1016/j.wneu.2016.09.066. Epub 2016 Sep 23.
3
The Role of Surgery in the Management of Prolactinomas.《泌乳素瘤的外科治疗作用》
Neurosurg Clin N Am. 2019 Oct;30(4):509-514. doi: 10.1016/j.nec.2019.05.010. Epub 2019 Jul 2.
4
Prolactin-producing pituitary adenomas.分泌催乳素的垂体腺瘤。
J Microsurg. 1979 Nov-Dec;1(3):182-6. doi: 10.1002/micr.1920010303.
5
Clinical Characteristics and Outcomes of Prolactinomas in Children and Adolescents: A Large Retrospective Cohort Study.儿童和青少年泌乳素瘤的临床特征与转归:一项大型回顾性队列研究
J Clin Endocrinol Metab. 2024 Aug 13;109(9):e1741-e1749. doi: 10.1210/clinem/dgad769.
6
Sellar Toxoplasmosis and Nonfunctioning Pituitary Adenoma.鞍区弓形虫病与无功能垂体腺瘤
World Neurosurg. 2015 Nov;84(5):1495.e1-4. doi: 10.1016/j.wneu.2015.05.029. Epub 2015 May 28.
7
Prolactinomas: Prognostic Factors of Early Remission After Transsphenoidal Surgery.催乳素瘤:经蝶窦手术后早期缓解的预测因素。
Front Endocrinol (Lausanne). 2020 Jul 7;11:439. doi: 10.3389/fendo.2020.00439. eCollection 2020.
8
Mucocele-like formation leading to neurological symptoms in prolactin-secreting pituitary adenomas under dopamine agonist therapy.多巴胺激动剂治疗下催乳素分泌型垂体腺瘤中导致神经症状的黏液囊肿样形成。
Surg Neurol. 1999 Sep;52(3):274-9. doi: 10.1016/s0090-3019(99)00081-6.
9
Invasive Giant Prolactinoma.侵袭性巨大泌乳素瘤。
World Neurosurg. 2024 Jan;181:21-22. doi: 10.1016/j.wneu.2023.10.025. Epub 2023 Oct 11.
10
Update on prolactinomas. Part 1: Clinical manifestations and diagnostic challenges.泌乳素瘤最新进展。第1部分:临床表现与诊断挑战。
J Clin Neurosci. 2015 Oct;22(10):1562-7. doi: 10.1016/j.jocn.2015.03.058.

本文引用的文献

1
Dopamine agonist therapy for prolactinomas: do we need to rethink the place of surgery in prolactinoma management?多巴胺激动剂治疗泌乳素瘤:我们是否需要重新思考手术在泌乳素瘤管理中的地位?
Endocr Oncol. 2022 Apr 21;2(1):R31-R50. doi: 10.1530/EO-21-0038. eCollection 2022 Jan.
2
Surgery as first-line treatment for prolactinoma? Discussion of the literature and results of a consecutive series of surgically treated patients.手术作为催乳素瘤的一线治疗方法?文献讨论和一系列连续手术治疗患者的结果。
Neurosurg Rev. 2023 May 30;46(1):128. doi: 10.1007/s10143-023-02033-0.
3
How to manage intolerance to dopamine agonist in patients with prolactinoma.
如何管理催乳素瘤患者对多巴胺激动剂的不耐受。
Pituitary. 2023 Apr;26(2):187-196. doi: 10.1007/s11102-023-01313-8. Epub 2023 Apr 7.
4
Macroprolactinoma with secondary resistance to dopamine agonists: a case report and review of the literature.大催乳素腺瘤继发于多巴胺激动剂抵抗:病例报告及文献复习。
J Med Case Rep. 2023 Mar 17;17(1):96. doi: 10.1186/s13256-023-03820-5.
5
Prolactinomas in adolescent and elderly patients-A comparative long-term analysis.青少年和老年患者的催乳素瘤——一项长期比较分析。
Front Surg. 2023 Feb 6;10:967407. doi: 10.3389/fsurg.2023.967407. eCollection 2023.
6
Treatment of hyperprolactinemia: A single-institute experience.高泌乳素血症的治疗:单中心经验。
J Chin Med Assoc. 2021 Nov 1;84(11):1019-1022. doi: 10.1097/JCMA.0000000000000584.
7
Depression and Impulsivity Self-Assessment Tools to Identify Dopamine Agonist Side Effects in Patients With Pituitary Adenomas.抑郁和冲动自我评估工具,以识别垂体腺瘤患者多巴胺激动剂的副作用。
Front Endocrinol (Lausanne). 2020 Oct 27;11:579606. doi: 10.3389/fendo.2020.579606. eCollection 2020.
8
Predictors of dopamine agonist resistance in prolactinoma patients.泌乳素瘤患者中多巴胺激动剂抵抗的预测因素。
BMC Endocr Disord. 2020 May 19;20(1):68. doi: 10.1186/s12902-020-0543-4.
9
Ki-67 and Clinical Correlations in Patients with Resistant Prolactinomas.Ki-67 与耐药性泌乳素瘤患者的临床相关性。
Ann Clin Lab Sci. 2020 Mar;50(2):199-204.
10
Surgery as a Viable Alternative First-Line Treatment for Prolactinoma Patients. A Systematic Review and Meta-Analysis.手术作为催乳素瘤患者一线治疗的可行选择:系统评价和荟萃分析。
J Clin Endocrinol Metab. 2020 Mar 1;105(3):e32-41. doi: 10.1210/clinem/dgz144.